Latest Close
$13.13
News
NTLA
Intellia Therapeutics, Inc. News
This news view pulls recent coverage and headlines tied to NTLA.
1y Change
$6.24 (+90.57%)
Market Cap
$1.55B
Sector
Healthcare
Industry
Biotechnology
Recommendation
buy
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire • Apr 3, 2026
Read articleTake the Zacks Approach to Beat the Markets: LiveOne, Micron, Clorox in Focus
Zacks • Mar 23, 2026
Read articleThis Cathie Wood Stock Is Up 47% This Year: Is It Too Late to Buy?
Motley Fool • Mar 8, 2026
Read articleA Look At Intellia Therapeutics (NTLA) Valuation After Its Recent Share Price Rebound
Simply Wall St. • Mar 5, 2026
Read articleRoblox initiated, Target upgraded: Wall Street's top analyst calls
The Fly • Mar 4, 2026
Read articleCathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Motley Fool • Mar 3, 2026
Read article